Cargando…

Mucosal Vaccination with Heterologous Viral Vectored Vaccine Targeting Subdominant SIV Accessory Antigens Strongly Inhibits Early Viral Replication

Conventional HIV T cell vaccine strategies have not been successful in containing acute peak viremia, nor in providing long-term control. We immunized rhesus macaques intramuscularly and rectally using a heterologous adenovirus vectored SIV vaccine regimen encoding normally weakly immunogenic tat, v...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Huanbin, Andersson, Anne-Marie, Ragonnaud, Emeline, Boilesen, Ditte, Tolver, Anders, Jensen, Benjamin Anderschou Holbech, Blanchard, James L., Nicosia, Alfredo, Folgori, Antonella, Colloca, Stefano, Cortese, Riccardo, Thomsen, Allan Randrup, Christensen, Jan Pravsgaard, Veazey, Ronald S., Holst, Peter Johannes
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5405164/ https://www.ncbi.nlm.nih.gov/pubmed/28302457 http://dx.doi.org/10.1016/j.ebiom.2017.03.003

Ejemplares similares

Virus-like vaccines against HIV/SIV synergize with a subdominant antigen T cell vaccine
por: Schwerdtfeger, Melanie, et al.
Publicado: (2019)

Systemic and Intestinal Viral Reservoirs in CD4+ T Cell Subsets in Primary SIV Infection
por: Wang, Xiaolei, et al.
Publicado: (2021)

Pre-Existing Vector Immunity Does Not Prevent Replication Deficient Adenovirus from Inducing Efficient CD8 T-Cell Memory and Recall Responses
por: Steffensen, Maria Abildgaard, et al.
Publicado: (2012)

Targeting of Non-Dominant Antigens as a Vaccine Strategy to Broaden T-Cell Responses during Chronic Viral Infection
por: Holst, Peter J., et al.
Publicado: (2015)

Increased Immunogenicity and Protective Efficacy of Influenza M2e Fused to a Tetramerizing Protein
por: Andersson, Anne-Marie Carola, et al.
Publicado: (2012)

Novel Antigenic Targets of HPV Therapeutic Vaccines
por: Boilesen, Ditte Rahbæk, et al.
Publicado: (2021)

Mucosal integrin α4β7 blockade fails to reduce the seeding and size of viral reservoirs in SIV‐infected rhesus macaques
por: Ziani, Widade, et al.
Publicado: (2021)

Subdominant Antigens in Bacterial Vaccines: AM779 Is Subdominant in the Anaplasma marginale Outer Membrane Vaccine but Does Not Associate with Protective Immunity
por: Albarrak, Saleh M., et al.
Publicado: (2012)

Immunogenic arenavirus vector SIV vaccine reduces setpoint viral load in SIV-challenged rhesus monkeys
por: Boopathy, Archana V., et al.
Publicado: (2023)

Vaccination and Timing Influence SIV Immune Escape Viral Dynamics In Vivo
por: Loh, Liyen, et al.
Publicado: (2008)

Th17 Cells Coordinate with Th22 Cells in Maintaining Homeostasis of Intestinal Tissues and both are Depleted in SIV-Infected Macaques
por: Xu, Huanbin, et al.
Publicado: (2014)

Prevention of Cytotoxic T Cell Escape Using a Heteroclitic Subdominant Viral T Cell Determinant
por: Butler, Noah S., et al.
Publicado: (2008)

Chronic hepatitis C viral infection subverts vaccine‐induced T‐cell immunity in humans
por: Kelly, Christabel, et al.
Publicado: (2016)

Highly-Immunogenic Virally-Vectored T-cell Vaccines Cannot Overcome Subversion of the T-cell Response by HCV during Chronic Infection
por: Swadling, Leo, et al.
Publicado: (2016)

Accessories to SIV Control: T Cell Vaccination Shows Potential
por: Robb, Merlin L., et al.
Publicado: (2017)

Optimising T cell (re)boosting strategies for adenoviral and modified vaccinia Ankara vaccine regimens in humans
por: Capone, Stefania, et al.
Publicado: (2020)

Incomplete Cd8(+) T Lymphocyte Differentiation as a Mechanism for Subdominant Cytotoxic T Lymphocyte Responses to a Viral Antigen
por: Spencer, Juliet V., et al.
Publicado: (2000)

Design and Immunological Validation of Macaca fascicularis Papillomavirus Type 3 Based Vaccine Candidates in Outbred Mice: Basis for Future Testing of a Therapeutic Papillomavirus Vaccine in NHPs
por: Neckermann, Patrick, et al.
Publicado: (2021)

Gag and env conserved element CE DNA vaccines elicit broad cytotoxic T cell responses targeting subdominant epitopes of HIV and SIV Able to recognize virus-infected cells in macaques
por: Hu, Xintao, et al.
Publicado: (2018)

Enhanced Vaccine-Induced CD8(+) T Cell Responses to Malaria Antigen ME-TRAP by Fusion to MHC Class II Invariant Chain
por: Spencer, Alexandra J., et al.
Publicado: (2014)

Distinct Expression Patterns of CD69 in Mucosal and Systemic Lymphoid Tissues in Primary SIV Infection of Rhesus Macaques
por: Wang, Xiaolei, et al.
Publicado: (2011)

CTL Escape and Viral Fitness in HIV/SIV Infection
por: Seki, Sayuri, et al.
Publicado: (2012)

The Insertion of an Evolutionary Lost Four-Amino-Acid Cytoplasmic Tail Peptide into a Syncytin-1 Vaccine Increases T- and B-Cell Responses in Mice
por: Skandorff, Isabella, et al.
Publicado: (2023)

P04-41. Kinetics of antibody neutralization and viral evolution following envelope vaccination in SIV-infected rhesus monkeys
por: Basavapathruni, A, et al.
Publicado: (2009)

TCR Affinity Associated with Functional Differences between Dominant and Subdominant SIV Epitope-Specific CD8(+) T Cells in Mamu-A*01 (+) Rhesus Monkeys
por: Osuna, Christa E., et al.
Publicado: (2014)

VACCINATIONS | Viral
por: Olszewska, W., et al.
Publicado: (2006)

Viral Vaccines
por: Schleiss, M.R.
Publicado: (2022)

Cancer Associated Endogenous Retroviruses: Ideal Immune Targets for Adenovirus-Based Immunotherapy
por: Vergara Bermejo, Amaia, et al.
Publicado: (2020)

Assessment of novel vaccination regimens using viral vectored liver stage malaria vaccines encoding ME-TRAP
por: Bliss, Carly M., et al.
Publicado: (2018)

Role of complement and antibodies in controlling infection with pathogenic simian immunodeficiency virus (SIV) in macaques vaccinated with replication-deficient viral vectors
por: Falkensammer, Barbara, et al.
Publicado: (2009)

Gag-specific cellular immunity determines in vitro viral inhibition and in vivo virologic control following SIV challenges of vaccinated monkeys
por: Stephenson, KE, et al.
Publicado: (2012)

Immunization with Single-Cycle SIV Significantly Reduces Viral Loads After an Intravenous Challenge with SIV(mac)239
por: Jia, Bin, et al.
Publicado: (2009)

Vaccine-Associated Enhanced Viral Disease: Implications for Viral Vaccine Development
por: Halstead, Scott B.
Publicado: (2021)

Characterizing Hepatitis C Virus–Specific CD4(+) T Cells Following Viral‐Vectored Vaccination, Directly Acting Antivirals, and Spontaneous Viral Cure
por: Hartnell, Felicity, et al.
Publicado: (2020)

Rapid Seeding of the Viral Reservoir Prior to SIV Viremia in Rhesus Monkeys
por: Whitney, James B., et al.
Publicado: (2014)

Estimating the contribution of the gut to plasma viral load in early SIV infection
por: Petravic, Janka, et al.
Publicado: (2013)

Transmissible Viral Vaccines
por: Bull, James J., et al.
Publicado: (2018)

Inactivated Viral Vaccines
por: Sanders, Barbara, et al.
Publicado: (2014)

Respiratory Viral Vaccines
por: Schmid, D. Scott, et al.
Publicado: (2005)

Viral vector vaccines
por: McCann, Naina, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2ffalvgnvhua5e9oan2d0t574n